"DioGenix, Inc. - Product Pipeline Analysis, 2013 Update" Now Available at Fast Market Research
DioGenix, Inc. (DGx) is a molecular diagnostics company. The company develops and commercializes non-invasive diagnostic, prognostic and treatment response monitoring tests. DGx's product MSPrecise, is test for the early diagnosis of multiple sclerosis based on measuring codon replacement frequencies in the variable region of immunoglobulin heavy chain genes in B cells isolated from cerebrospinal fluid and peripheral blood B cells. It identifies and exploits biomarkers that correlate with disease activity and response to therapy. The company offers tests for measuring...
View full press release